Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia

Bilateral pallidal stimulation is effective in the treatment of patients with generalised idiopathic dystonia. The aim of this study is to evaluate the efficacy of bilateral pallidal stimulation in patients with post-anoxic generalised dystonia or non-generalised primary dystonia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dystonia Dyskinesias Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

15 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere

Paris, France

About this study

Evaluate the effect of bilateral pallidal stimulation on the motor disability of patients with post-anoxic generalised dystonia or primary dystonia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Post-anoxic generalised dystonia
Idiopathic non-generalised dystonia
Disease duration > 1 year

Exclusion criteria

Contraindication to magnetic resonance imaging (MRI)
Mini-mental status (MMS) < 24
Severe psychiatric disorder

Treatment and study plan

Deep Brain Stimulation

Procedure

internal pallidal deep brain stimulation

Sponsors and collaborators

Lead sponsor

Marie-laure Welter

Other

Registry information

Important dates

Study start: 2005
Primary completion: 2014
Study completion: 2014
First posted: Sep 15, 2005
Registry last updated: Sep 15, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed